Navigation Links
The Crohn's & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners
Date:6/24/2009

n's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 81 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance (give.org) and the American Institute of Philanthropy (charitywatch.org). For more information, contact the Foundation at 800-932-2423 or visit www.ccfa.org.

About Procter & Gamble (NYSE: PG)

Three billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Actonel(R) (risedronate sodium) tablets, Enablex(R) (darifenacin) extended-release tablets, Prilosec OTC(R), Metamucil(R), Fibersure(R), Align(R), Pepto-Bismol(R), Vicks(R), PUR(R), Crest(R) and Oral-B(R). The P&G community consists of more than 135,000 employees working in more than 80 countries worldwide. For more information on P&GP and its prescription product portfolio, please visit www.pgpharma.com.


'/>"/>
SOURCE Crohn's & Colitis Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Mouse Study Gives Clues to Colitis
2. New therapeutic targets in the treatment of ulcerative colitis
3. Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients
4. Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives
5. Although Remicade and Humira Are Being Increasingly Prescribed for Crohns Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies
6. Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis
7. Medical Futures signs North American licensing rights to New Biologic agent for Ulcerative Colitis
8. A rare case of ischemic colitis caused by chronic venous insufficiency
9. Study underway to find an alternative cure for Crohns disease and ulcerative colitis
10. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
11. Can rectal vitamin E induce remission in patients with mild to moderate ulcerative colitis?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 The Latin America Drilling fluid and ... and completion fluid market in Latin America with analysis and ... in Latin America is estimated to grow from around $0.93 ... CAGR of 9.2%, for the given period. , Browse through ... fluid Market Report, to get an idea of the in-depth ...
(Date:7/22/2014)... The donation from the Edusei Foundation was greatly appreciated by ... of strategic engineering, such assistance tends to etch good memories ... It provided a sense of family to them, which the ... Foundation donated various amounts of; milk, soap, frytol, sugar, ... Government of Ghana established the Kumasi Children’s Home in 1965 ...
(Date:7/22/2014)... The Middle East Drilling fluid and Completion fluid Market ... market in Middle East with analysis and forecast of revenue. ... is estimated to grow from around $560 million in 2013 ... for the given period. , Browse through the TOC of ... to get an idea of the in-depth analysis provided. This ...
(Date:7/22/2014)... 22, 2014 According to ... Market Research “Circulating Circulating Tumor Cells (CTCs) ... (Filtration, Centrifugation and Immunological & Immunomagnetic Methods) ... Optical Methods) and Applications: Prostate Cancer, Breast ... Industry Analysis, Size, Share, Growth, Trends and ...
(Date:7/22/2014)... Carlsbad, CA (PRWEB) July 22, 2014 ... 0% financing for 24 months on all models during ... 18th-28th. , Please visit http://www.d1spas.com/financing for ... leader in hydrotherapy, Dimension One Spas offers a wide ... your fingertips including lights, fountains, waterfalls, music, customizable massage, ...
Breaking Medicine News(10 mins):Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 6Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 2Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 3Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 4
... a recent research, drinking cola can lead to brittle bones ... the carbonated drink women consumed, the weaker// were their bones. ... advised not to drink too much of cola. The phosphoric ... drinks, is assumed to be responsible for the problem. ...
... Health Organization (WHO) for the first time issued Global Air ... air pollution that kills 2 million// people each year with ... ,The WHO appealed to governments to enhance air quality in ... in Manila revealed that almost 3,00,000 lives could be saved ...
... to cause deaths in women in developing countries is ... of deaths caused// because of uncontrolled bleeding following childbirth ... and studies conducted by researchers from the University of ... Institutes of Health . The studies have come to ...
... on the Indonesian resort island of Bali were in stable ... case, but so far they are stable," Wayan Sutarga, director ... Denpasar, told DPA., ,"We are still examining the babies, ... said, adding that in medical terms the girls are thoraco ...
... National Osteoporosis Foundation has estimated that nearly 55 percent ... osteoporosis, a disease of porous and brittle bones// that ... beverage among Americans has been found to contribute to ... studies conducted by Katherine Tucker, PhD, director of the ...
... C has become the scourge of multitude of Queenslanders, with ... disease//, underlining the importance of early medical intervention in the ... by a virus that targets the liver, which can also ... rolled out figures that show the alarming rise of Hepatitis ...
Cached Medicine News:Health News:Cola increases risk of Osteoporosis!! 2Health News:A Safe Drug For Safe Delivery 2Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 2Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 3
(Date:7/22/2014)... Mass. , July 22, 2014  Decision ... audited multiple sclerosis (MS) patients currently treated ... Tecfidera have ever experienced flushing and/or gastrointestinal ... Tecfidera-treated patients are currently experiencing these side ... the effective medical management of such events. ...
(Date:7/22/2014)... ALBANY, New York , July 22, 2014 ... published by Transparency Market Research "Process Spectroscopy Market (Technology Types ... infrared (FT-IR) spectroscopy) Market - Global Industry Analysis, Size, Share, ... valued at USD 714.5 million in 2012 and is expected ... 2019. North America was ...
(Date:7/22/2014)... -- Research and Markets  has announced the addition ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... monitor, and assess medical conditions, diseases, or infections usually ... earlier and more targeted treatment. These tests are minimally ... This kind of diagnostics provides early detection of diseases ...
Breaking Medicine Technology:Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 2Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 4Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3
... Millennium: The Takeda Oncology,Company today reported ... III clinical trials of VELCADE based combinations ... previously untreated,multiple myeloma (MM). Prolonged progression-free survival ... and dexamethasone (VcD) with vincristine,adriamycin and dexamethasone ...
... 8 Alexion Pharmaceuticals,Inc. (Nasdaq: ... AEGIS, an open-label,registration study examining Soliris(R) (eculizumab) ... (PNH). The pre-specified,primary efficacy endpoint of change ... reduction (P<0.001). Key secondary endpoints including fatigue,(P<0.001) ...
Cached Medicine Technology:Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 2Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 3Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 4Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 5Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 6Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 8
... not restricted to small central fields, ... are full field capable, all encompassing ... you'll ever need to ensure the ... They also include the most important ...
... an innovative device designed to be a ... abdominal aortic aneurysms (AAA). It is constructed ... an outer self-expanding Nitinol support structure to ... The function of the endoprosthesis is to ...
... to remove a cast from an arm or ... patients are cut or burned by the cast ... professionals to remove any cast with confidence. This ... cuts and burns from the cast saw and ...
... creation of a vascular access, a correctly ... the utmost importance in many vascular procedures. ... seeking a high-precision tunneling instrument. The unique ... twisting or kinking for more accurate graft ...
Medicine Products: